Halberd Co. (OTCMKTS:HALB) Short Interest Up 208.2% in June

Halberd Co. (OTCMKTS:HALB) was the target of a significant increase in short interest in the month of June. As of June 15th, there was short interest totaling 409,891 shares, an increase of 208.2% from the May 31st total of 133,008 shares. Based on an average daily trading volume, of 1,861,083 shares, the days-to-cover ratio is currently 0.2 days.

Halberd Stock Performance

Shares of HALB stock opened at $0.00 on Tuesday. Halberd has a fifty-two week low of $0.00 and a fifty-two week high of $0.00.

About Halberd

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.